Press

Freespira Finalizes $10 Million Financing to Support Commercialization of Digital Therapeutic for Treatment of Panic Disorder and PTSD
Freespira Finalizes $10 Million Financing to Support Commercialization of Digital Therapeutic for Treatment of Panic Disorder and PTSD
  • February 9, 2022Freespira Marketing
  • Category
  • Category
  • Category

Freespira, Inc. is the new name of Palo Alto Health Sciences KIRKLAND, WA, December 8, 2020 – Freespira, Inc., maker…

Stressed about the election results?
Stressed about the election results?
  • February 9, 2022Freespira Marketing
  • Category
  • Category
  • Category

Uncertainty over #election2020 can trigger an anxious mind. Our Chief Clinical Officer Dr. Robert Cuyler gives practical advice to manage…

Palo Alto Health Sciences Obtains FDA-Clearance for Freespira in Treating Post-Traumatic Stress Disorder
Palo Alto Health Sciences Obtains FDA-Clearance for Freespira in Treating Post-Traumatic Stress Disorder
  • February 9, 2022Freespira Marketing
  • Category
  • Category
  • Category

KIRKLAND, Wash., Dec. 18, 2018 /PRNewswire/ — Palo Alto Health Sciences, Inc. (PAHS) announced today that its flagship digital therapeutic, Freespira®, has…